Nonsyndromic craniosynostosis: novel coding variants

Anshuman Sewda, Sierra R White, Monica Erazo, Ke Hao, Gemma García-Fructuoso, Ivette Fernández-Rodriguez, Yann Heuzé, Joan T Richtsmeier, Paul A Romitti, Boris Reva, Ethylin Wang Jabs, Inga Peter, Anshuman Sewda, Sierra R White, Monica Erazo, Ke Hao, Gemma García-Fructuoso, Ivette Fernández-Rodriguez, Yann Heuzé, Joan T Richtsmeier, Paul A Romitti, Boris Reva, Ethylin Wang Jabs, Inga Peter

Abstract

Background: Craniosynostosis (CS), the premature fusion of one or more neurocranial sutures, is associated with approximately 200 syndromes; however, about 65-85% of patients present with no additional major birth defects.

Methods: We conducted targeted next-generation sequencing of 60 known syndromic and other candidate genes in patients with sagittal nonsyndromic CS (sNCS, n = 40) and coronal nonsyndromic CS (cNCS, n = 19).

Results: We identified 18 previously published and 5 novel pathogenic variants, including three de novo variants. Novel variants included a paternally inherited c.2209C>G:p.(Leu737Val) variant in BBS9 of a patient with cNCS. Common variants in BBS9, a gene required for ciliogenesis during cranial suture development, have been associated with sNCS risk in a previous genome-wide association study. We also identified c.313G>T:p.(Glu105*) variant in EFNB1 and c.435G>C:p.(Lys145Asn) variant in TWIST1, both in patients with cNCS. Mutations in EFNB1 and TWIST1 have been linked to craniofrontonasal and Saethre-Chotzen syndrome, respectively; both present with coronal CS.

Conclusions: We provide additional evidence that variants in genes implicated in syndromic CS play a role in isolated CS, supporting their inclusion in genetic panels for screening patients with NCS. We also identified a novel BBS9 variant that further shows the potential involvement of BBS9 in the pathogenesis of CS.

Conflict of interest statement

Disclosure: The authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Functional consequences of novel mutations: (a) TWIST1 p.(Lys145Asn) acts as a transcriptional regulator for cranial suture patterning and fusion. The mutation affects the evolutionarily conserved residue and one of the key binding site residues. Functional impact predicted by Mutation Assessor is ‘Medium’. (b) TWIST1 p.(Asp141His) mutation affects one of the high-scoring specificity residues, i.e. residues conserved within protein subfamilies. Functional impact predicted by Mutation Assessor is ‘Medium’. (c) BBS9 p.(Leu737Val) is required for proper BBSome complex assembly which is required for ciliogenesis. The mutation affects the evolutionarily conserved residue. Functional impact predicted by Mutation Assessor is ‘High’. (d) ALX4 p.(Lys42Asn) encodes a paired-like homeodomain transcription factor expressed in the mesenchyme of developing bones. The mutation affects the evolutionarily conserved residue.

References

    1. Flaherty K, Singh N, Richtsmeier JT. Understanding craniosynostosis as a growth disorder. Wiley Interdiscip Rev Dev Biol 2016;5:429–59.
    1. Cornelissen M, Ottelander B, Rizopoulos D, et al. Increase of prevalence of craniosynostosis. J Craniomaxillofac Surg 2016;44:1273–9.
    1. Greenwood J, Flodman P, Osann K, Boyadjiev SA, Kimonis V. Familial incidence and associated symptoms in a population of individuals with nonsyndromic craniosynostosis. Genet Med 2014;16:302–10.
    1. Cohen MM, MacLean RE. Craniosynostosis : diagnosis, evaluation, and management. 2nd ed. New York: Oxford University Press; 2000.
    1. Wilkie AOM, Johnson D, Wall SA. Clinical genetics of craniosynostosis. Current opinion in pediatrics 2017;29:622–8.
    1. Hunter AG, Rudd NL. Craniosynostosis. II. Coronal synostosis: its familial characteristics and associated clinical findings in 109 patients lacking bilateral polysyndactyly or syndactyly. Teratology 1977;15:301–9.
    1. Lajeunie E, Le Merrer M, Bonaiti-Pellie C, Marchac D, Renier D. Genetic study of nonsyndromic coronal craniosynostosis. American journal of medical genetics 1995;55:500–4.
    1. Selber J, Reid RR, Chike-Obi CJ, et al. The changing epidemiologic spectrum of single-suture synostoses. Plastic and reconstructive surgery 2008;122:527–33.
    1. Lajeunie E, Le Merrer M, Bonaiti-Pellie C, Marchac D, Renier D. Genetic study of scaphocephaly. American journal of medical genetics 1996;62:282–5.
    1. Lajeunie E, Crimmins DW, Arnaud E, Renier D. Genetic considerations in nonsyndromic midline craniosynostoses: a study of twins and their families. J Neurosurg 2005;103:353–6.
    1. Justice CM, Yagnik G, Kim Y, Peter I, Jabs EW, Erazo M, Ye X, Ainehsazan E, Shi L, Cunningham ML, Kimonis V, Roscioli T, Wall SA, Wilkie AO, Stoler J, Richtsmeier JT, Heuze Y, Sanchez-Lara PA, Buckley MF, Druschel CM, Mills JL, Caggana M, Romitti PA, Kay DM, Senders C, Taub PJ, Klein OD, Boggan J, Zwienenberg-Lee M, Naydenov C, Kim J, Wilson AF, Boyadjiev SA 2012. A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet 44:1360–1364.
    1. Lee E, Le T, Zhu Y, et al. A craniosynostosis massively parallel sequencing panel study in 309 Australian and New Zealand patients: findings and recommendations. Genet Med 2017.
    1. Apostolopoulou D, Kaxira OS, Hatzaki A, et al. Genetic Analysis of Syndromic and Nonsyndromic Patients With Craniosynostosis Identifies Novel Mutations in the TWIST1 and EFNB1 Genes. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 2018:1055665618760412.
    1. Clarke CM, Fok VT, Gustafson JA, et al. Single suture craniosynostosis: Identification of rare variants in genes associated with syndromic forms. American journal of medical genetics Part A 2018;176:290–300.
    1. Ye X, Guilmatre A, Reva B, et al. Mutation Screening of Candidate Genes in Patients with Nonsyndromic Sagittal Craniosynostosis. Plastic and reconstructive surgery 2016;137:952–61.
    1. Cingolani P, Platts A, Wang le L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 2012;6:80–92.
    1. Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic acids research 2012;40:W452–7.
    1. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nature methods 2010;7:248–9.
    1. Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nature genetics 2014;46:310–5.
    1. Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic acids research 2011;39:e118.
    1. Veleri S, Bishop K, Dalle Nogare DE, et al. Knockdown of Bardet-Biedl syndrome gene BBS9/PTHB1 leads to cilia defects. PloS one 2012;7:e34389.
    1. Katsianou MA, Adamopoulos C, Vastardis H, Basdra EK. Signaling mechanisms implicated in cranial sutures pathophysiology: Craniosynostosis. BBA Clin 2016;6:165–76.
    1. Lattanzi W, Barba M, Di Pietro L, Boyadjiev SA. Genetic advances in craniosynostosis. American journal of medical genetics Part A 2017;173:1406–29.
    1. Heuze Y, Holmes G, Peter I, Richtsmeier JT, Jabs EW. Closing the Gap: Genetic and Genomic Continuum from Syndromic to Nonsyndromic Craniosynostoses. Current genetic medicine reports 2014;2:135–45.
    1. Compagni A, Logan M, Klein R, Adams RH. Control of skeletal patterning by ephrinB1-EphB interactions. Developmental cell 2003;5:217–30.
    1. Merrill AE, Bochukova EG, Brugger SM, et al. Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis. Human molecular genetics 2006;15:1319–28.
    1. Ting MC, Wu NL, Roybal PG, et al. EphA4 as an effector of Twist1 in the guidance of osteogenic precursor cells during calvarial bone growth and in craniosynostosis. Development 2009;136:855–64.
    1. Howard TD, Paznekas WA, Green ED, et al. Mutations in TWIST, a basic helix-loophelix transcription factor, in Saethre-Chotzen syndrome. Nature genetics 1997;15:36–41.
    1. Seto ML, Hing AV, Chang J, et al. Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations. American journal of medical genetics Part A 2007;143A:678–86.
    1. Bertola DR, Rodrigues MG, Quaio CR, Kim CA, Passos-Bueno MR. Vertical transmission of a frontonasal phenotype caused by a novel ALX4 mutation. American journal of medical genetics Part A 2013;161A:600–4.
    1. Wu YQ, Badano JL, McCaskill C, Vogel H, Potocki L, Shaffer LG. Haploinsufficiency of ALX4 as a potential cause of parietal foramina in the 11p11.2 contiguous gene-deletion syndrome. American journal of human genetics 2000;67:1327–32.
    1. Vona B, Muller T, Nanda I, et al. Targeted next-generation sequencing of deafness genes in hearing-impaired individuals uncovers informative mutations. Genet Med 2014;16:945–53.
    1. Wang Y, Zhou X, Oberoi K, et al. p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice. The Journal of clinical investigation 2012;122:2153–64.
    1. Shukla V, Coumoul X, Wang RH, Kim HS, Deng CX. RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis. Nature genetics 2007;39:1145–50.
    1. Melville H, Wang Y, Taub PJ, Jabs EW. Genetic basis of potential therapeutic strategies for craniosynostosis. American journal of medical genetics Part A 2010;152A:3007–15.
    1. Yin L, Du X, Li C, et al. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis. Bone 2008;42:631–43.
    1. Perlyn CA, Morriss-Kay G, Darvann T, Tenenbaum M, Ornitz DM. A model for the pharmacological treatment of crouzon syndrome. Neurosurgery 2006;59:210–5; discussion −5.
    1. Eswarakumar VP, Ozcan F, Lew ED, et al. Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis. Proc Natl Acad Sci U S A 2006;103:18603–8.
    1. Goriely A, Lord H, Lim J, et al. Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in “paternal age-effect” syndromes. American journal of medical genetics Part A 2010;152A:2067–73.
    1. Robin NH, Scott JA, Cohen AR, Goldstein JA. Nonpenetrance in FGFR3-associated coronal synostosis syndrome. American journal of medical genetics 1998;80:296–7.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi